Sandy Smith

(Mr. Sandford Smith)

Currently holds positions in Genzyme Corp, Seneca Biopharma Inc and Akcea Therapeutics Inc

Positions

Position Company Period
Executive Vice President, President - International Group Genzyme Corp June 1, 2006 -
Independent Director Seneca Biopharma Inc March 1, 2014 -
Independent Director Akcea Therapeutics Inc March 15, 2017 -
Independent Director Seelos Therapeutics Inc Aug. 5, 2014 - Jan. 24, 2019
Sandy Smith's trades of Cytokinetics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-02 2022-09-02
S Sale
11,369 -48.3%
53.97
USD 613,585 		11,369 -48.3% 53.97 USD 613,585
2021-11-19 2021-11-19
S Sale
4,032 -37.3%
41.21
USD 166,140 		4,032 -37.3% 41.21 USD 166,140
2021-11-19 2021-11-19
S Sale
20,000 -74.7%
41.21
USD 824,108 		20,000 -74.7% 41.21 USD 824,108
2021-11-19 2021-11-19
S Sale
5,000 -42.5%
41.21
USD 206,027 		5,000 -42.5% 41.21 USD 206,027
2021-07-21 2021-07-19
PS Planned sale
5,000 -43.6%
28.50
USD 142,500 		5,000 -43.6% 28.50 USD 142,500
2021-07-21 2021-07-19
PS Planned sale
1,965 -23.3%
29.50
USD 57,968 		1,965 -23.3% 29.50 USD 57,968
2021-07-21 2021-07-19
PS Planned sale
5,000 -43.6%
29.00
USD 145,000 		5,000 -43.6% 29.00 USD 145,000
2021-04-27 2021-04-27
PS Planned sale
5,000 -84.5%
28.00
USD 140,000 		5,000 -84.5% 28.00 USD 140,000
2021-04-27 2021-04-27
PS Planned sale
4,739 -83.7%
27.50
USD 130,323 		4,739 -83.7% 27.50 USD 130,323
2021-04-23 2021-04-23
PS Planned sale
5,000 -84.5%
26.50
USD 132,500 		5,000 -84.5% 26.50 USD 132,500
2021-04-15 2021-04-15
PS Planned sale
5,714 -86.1%
25.00
USD 142,850 		5,714 -86.1% 25.00 USD 142,850
2021-04-15 2021-04-15
PS Planned sale
5,000 -84.5%
25.50
USD 127,500 		5,000 -84.5% 25.50 USD 127,500
2020-10-05 2020-10-05
PS Planned sale
5,936 -100.0%
30.00
USD 178,080 		5,936 -100.0% 30.00 USD 178,080
2020-07-17 2020-07-15
PS Planned sale
6,667 -100.0%
29.00
USD 193,343 		6,667 -100.0% 29.00 USD 193,343
2020-07-13 2020-07-10
PS Planned sale
6,667 -100.0%
28.00
USD 186,676 		6,667 -100.0% 28.00 USD 186,676
2020-07-09 2020-07-08
PS Planned sale
1,434 -100.0%
27.00
USD 38,718 		1,434 -100.0% 27.00 USD 38,718
2020-07-09 2020-07-07
PS Planned sale
6,510 -100.0%
26.00
USD 169,260 		6,510 -100.0% 26.00 USD 169,260
2020-07-09 2020-07-07
PS Planned sale
5,232 -100.0%
27.00
USD 141,264 		5,232 -100.0% 27.00 USD 141,264
2020-06-22 2020-06-22
S Sale
5,000 -100.0%
24.00
USD 120,000 		5,000 -100.0% 24.00 USD 120,000
2020-06-22 2020-06-22
S Sale
5,000 -100.0%
25.00
USD 125,000 		5,000 -100.0% 25.00 USD 125,000
2020-06-17 2020-06-17
S Sale
2,741 -100.0%
23.00
USD 63,043 		2,741 -100.0% 23.00 USD 63,043
2020-06-17 2020-06-17
S Sale
4,166 -100.0%
23.00
USD 95,818 		4,166 -100.0% 23.00 USD 95,818
2020-06-15 2020-06-15
S Sale
6,666 -100.0%
22.00
USD 146,652 		6,666 -100.0% 22.00 USD 146,652
2020-06-12 2020-06-12
S Sale
4,166 -100.0%
21.10
USD 87,903 		4,166 -100.0% 21.10 USD 87,903
2020-06-12 2020-06-12
S Sale
10,879 -100.0%
20.77
USD 226,005 		10,879 -100.0% 20.77 USD 226,005
2014-10-24 2014-10-23
B Purchase
18,200 +219.3%
1.59
USD 28,998 		18,200 +219.3% 1.59 USD 28,998
2014-10-24 2014-10-22
B Purchase
8,300 +inf%
1.52
USD 12,651 		8,300 +inf% 1.52 USD 12,651
// ... existing code ... // ... rest of the file ...